000 01207 a2200325 4500
005 20250514035911.0
264 0 _c20030210
008 200302s 0 0 eng d
022 _a0890-9091
040 _aNLM
_beng
_cNLM
100 1 _aLogothetis, Christopher
245 0 0 _aDocetaxel in the management of advanced or metastatic urothelial tract cancer.
_h[electronic resource]
260 _bOncology (Williston Park, N.Y.)
_cJun 2002
300 _a107-11 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents, Phytogenic
_xadverse effects
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCarcinoma, Transitional Cell
_xdrug therapy
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aClinical Trials, Phase II as Topic
650 0 4 _aDeoxycytidine
_xadministration & dosage
650 0 4 _aDocetaxel
650 0 4 _aHumans
650 0 4 _aPaclitaxel
_xadverse effects
650 0 4 _aTaxoids
650 0 4 _aUrologic Neoplasms
_xdrug therapy
650 0 4 _aGemcitabine
700 1 _aMillikan, Randall
773 0 _tOncology (Williston Park, N.Y.)
_gvol. 16
_gno. 6 Suppl 6
_gp. 107-11
999 _c12000257
_d12000257